Indian markets ended the week down 2.7%, dragged by IT and pharma amid U.S. tariff and visa fee worries. Key drivers ahead include RBI policy outcome, U.S. market cues, IPO rush, rupee weakness, and crude price trends. Analysts suggest caution with focus on fundamentally strong stocks.
